Cancers potentially driven by TrkA oncogenes include paediatric neuroblastomas (NBs), a significant proportion of which express the oncogenic alternative TrkA splice variant, TrkAIII. The gene discussed is NTRK1; the disease is Nijmegen breakage syndrome.